Zurueck zur Suche

Reporte zur Charge U010400

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 4 TX 3 IL 2 PA 1

VAERS 2355640

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
PA
Alter
-
Geschlecht
M
Eingang
03.07.2022
Impfdatum
14.06.2022
Beginn
14.06.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

MMR # of previous doses: 3; indicate at which point in the process the medication error occured: dispensing; No additional AE details provided.; Varivax # of previous doses: 2/ MMR # of previous doses: 3; MOA calling to report expired MMR II had been administered to a patient. Product and sterile diluent used to reconstitute product had not experienced any temperature excursions.; This spontaneous report was received from the Medical Office Assistant (MOA) and refers to a 24-year-old male patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included hepatitis b vaccine rhbsag (yeast) (ENGERIX B) and diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP). On an unknown date, the patient was vaccinated with the 3 dose of the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (extra dose administered) (dose, route of administration, anatomical location, strength, expiry date and lot number were not provided). On an unknown date, the dispensing medication error occurred and the expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA type: recombinant human albumin) was dispensed. On 14-JUN-2022, it was administered to the patient, already as a 4th dose of this product (3 previous doses reported) (extra dose administered), subcutaneous injection, lot #T018669, expiry date: 29-MAY-2022, for prophylaxis (strength and dose not provided), with the sterile diluent, used to reconstitute the product (lot number: U005973, expiry date reported as 08-APR-2023, but validated as 09-APR-2023). On the same day, additionally the varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection was given to the patient, as a third dose already (two previous doses reported) (extra dose administered), lot #U010400, expiration date: 01-APR-2023, for prophylaxis (strength and dose was not provided). On 14-JUN-2022, the 4th dose of hepatitis b vaccine rhbsag (yeast) (ENGERIX B) (3 previous doses) and 2nd dose of diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP) (1 previous dose) were also administered. No additional adverse event details were provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT; ENGERIX B; TDAP
Allergien
-
Vorherige Impfungen
-

VAERS 2334815

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
IL
Alter
1,0
Geschlecht
U
Eingang
25.06.2022
Impfdatum
17.06.2022
Beginn
17.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event

Symptomtext

No additional AEs; PROQUAD and VARIVAX administered to 12 month old at same visit; This spontaneous report was received from a registered nurse and refers to a 12-month-old patient of unknown gender. The patient's pertinent medical history, concomitant therapies, drug reactions and allergies were not reported. On 17-JUN-2022, at the same visit, the patient was administered measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant Human albumin (rHA) (PROQUAD), 0.5 ml, lot #U010746, expiration date was not provided but upon internal validation was determined to be 03-OCT-2022; and varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 ml, lot #U010400, expiration date was not provided but upon internal validation was determined to be 01-APR-2023, both vaccines administered subcutaneously for prophylaxis (vaccine overdose). No additional adverse events (AEs) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2174726

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
12.03.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

an improperly stored dose of VARIVAX; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 22-FEB-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) lot # U010400, expiration date: 01-APR-2023, dose: 0,5 ml (route of administration, dose number were not reported) for prophylaxis (product storage error). Administered dose of vaccine experienced the temperature excursion of 9 degrees Fahrenheit (F) for 293 hours and 14 minutes. There were no previous temperature excursion. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2202USA007938: US-009507513-2202USA008282: US-009507513-2202USA007865:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2172577

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
11.03.2022
Impfdatum
17.02.2022
Beginn
17.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional information provided; an improperly stored dose of varivax was administered to a patient on 17-FEB-2022; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-FEB-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 ml, lot # U010400, expiration date 01-APR-2023 (formulation, dose number, site and route of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 9 degrees Fahrenheit for 293 hours and 14 minutes. No previous temperature excursions reported. No additional information provided (no adverse event).; Sender's Comments: US-009507513-2202USA007938: US-009507513-2202USA008270: US-009507513-2202USA007865:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2066204

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
TX
Alter
1,1
Geschlecht
F
Eingang
26.01.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Vaccination error

Symptomtext

Vaccination error: Pt was given MMRV and Varicella together during today's visit (01/26/2022) for immunizations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1787437

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
MI
Alter
4,0
Geschlecht
U
Eingang
15.10.2021
Impfdatum
14.09.2021
Beginn
14.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE/PQC reported; a temperature excursion for VARlVAX, vaccine have been administered; This spontaneous report has been received from a registered nurse (also reported as medical assistant) referring to a 4 years old patient. Information about concurrent condition, concomitant medication and medical history was not provided. On 14-SEP-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (dose: 1(unit not provided), lot#: U010400 with expire date 01-APR-2023; strength and route were not reported) for prophylaxis (product storage error). The vaccine experienced an excursion of -10 degree Celsius to 8 degree Celsius (4C) for 20 minutes on 07-SEP-2021 during transport and -10 degree Celsius to 8 degree Celsius (4C) for 20 minutes on 09-SEP-2021 during transport. Previous temperature excursion was -10 degree Celsius to 8 degree Celsius for 7 hours and 30 minutes. No adverse events reported. This is one of several reports from the same reporter.; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1768924

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
IL
Alter
6,0
Geschlecht
F
Eingang
07.10.2021
Impfdatum
07.10.2021
Beginn
07.10.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

When identifying the patient, the mother was unclear which child was which despite the identification process and placed the wrong child in the chair for her shots, despite a second check in indicating the type of shots she was getting that day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1755663

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
02.10.2021
Impfdatum
15.09.2021
Beginn
15.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; patient was administered with an improperly stored dose of VARIVAX; This spontaneous report as received from a registered nurse refers to a 4 year old patient. On 15-SEP-2021, the patient was vaccinated with an improperly store dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U010400 exp date 01-APR-2023) (dose and route not reported). The vaccine experienced an excursion of (4?C) for 20 minutes on 07-SEP-2021 during transport and (4?C) for 20 minutes on 09-SEP-2021 during transport. This is one of several reports received from the same source.; Sender's Comments: US-009507513-2109USA005628: US-009507513-2109USA005910: US-009507513-2109USA005742: US-009507513-2109USA005891: US-009507513-2109USA005964: US-009507513-2109USA005651: US-009507513-2109USA005918: US-009507513-2109USA005744: US-009507513-2109USA005648: US-009507513-2109USA005758: US-009507513-2109USA005628: US-009507513-2109USA005776: US-009507513-2109USA005901: US-009507513-2109USA005639: US-009507513-2109USA005662: US-009507513-2109USA005752: US-009507513-2109USA005641: US-009507513-2109USA005945: US-009507513-2109USA005618: US-009507513-2109USA005760: US-009507513-2109USA005881: US-009507513-2109USA005902:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1740506

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
MI
Alter
7,0
Geschlecht
U
Eingang
28.09.2021
Impfdatum
15.09.2021
Beginn
15.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE's/PQC's reported.; products experienced an excursion of ( 4C) for 20 minutes on 9/7; This spontaneous report was received from a registered nurse (also reported as medical assistant) referring to a 7-year old patient of unknown gender. The patient's pertinent medical history, drug allergies/reactions and concomitant medication were not provided. Per reporter, varicella virus vaccine live (oka/merck) (VARIVAX) with lot# U015682, U002394, and U010400 experienced an excursion of minus 10 degree Celsius to 8 degree Celsius (4 degree Celsius) for 20 minutes on 07-SEP-2021 during transport and minus 10 degree Celsius to 8 degree Celsius (4 degree Celsius) for 20 minutes on 09-SEP-2021 during transport. On 15-SEP-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U010400, expiration date 01-APR-2023, dose: 1 (unit unknown); strength and route were unknown) for prophylaxis (product storage error). No additional adverse event and product quality complaint reported. This is one of several reports received from same reporter.; Sender's Comments: US-009507513-2109USA005628:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1733752

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U010400

gering
Staat
MI
Alter
1,5
Geschlecht
U
Eingang
25.09.2021
Impfdatum
15.09.2021
Beginn
15.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AEs; temperature excursion for VARlVAX; This spontaneous report was received from a nurse referring to an 18-months-old patient of unknown gender. For all the patients, the concurrent conditions, medical history and concomitant medications were not provided. On 15-SEP-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose (strength, dose, route, frequency, were not provided) for prophylaxis; Lot No. U010400 has been verified to be a valid lot number for [varicella virus vaccine live (Oka/Merck)], expiration date reported as 01-MAR-2023, and upon internal validation established as the same. The nurse reported that the vaccine dose was administered on 15-SEP-2021 and there was a temperature excursion for varicella virus vaccine live (Oka/Merck) (VARIVAX). The product experienced an excursion of 4 Celsius degrees (C) from -10 C to 8 C for 20 minutes on 07-SEP-2021 during the transport; and of 4C from -10 C to 8 C for 20 minutes on 09-SEP-2021, again during transport. Previous temperature excursion included from -10?C to 8?C (4C) for 7 hours and 30 minutes. And no adverse events were reported. This is one of four reports received from the same source.; Sender's Comments: US-009507513-2109USA005618: US-009507513- 2109USA005639: US-009507513-2109USA005632:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-